Antabus 400 mg, Brausetabletten

7680151040150 CH-15104 Brausetabletten
Antabus 400 mg, Brausetabletten
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
50
Selling units
50
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/02/2026
Patient information leaflet
Français
13/02/2026
Patient information leaflet
Italien
13/02/2026
Summary of Product Characteristics
Allemand
13/02/2026
Summary of Product Characteristics
Français
13/02/2026
Summary of Product Characteristics
Italien
13/02/2026

Detailed composition

Substance Quantity Type Category
disulfiramum
400.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 20
- Substance HNIDK
maydis amylum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
acidum tartaricum
- Substance HNIDK
natrii hydrogenocarbonas
- Substance HNIDK
natrium
13.14 MG Substance HBESI
talcum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK

Reimbursement information

Public price
CHF 46.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1996

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
15104
Drug name
Antabus, Brausetabletten
Galenic form
BRAT
ATC Code
N07BB01
Authorization status
Z
Dispensing category
B
First authorization
01/12/1949
Authorization expiration date
31/12/9999
IT Number
15.02.0.
Domain
Human medicine
Field of application
Unterstützende Behandlung von chronischem Alkoholismus

Package details

Description (FR)
ANTABUS dispergettes cpr 400 mg bte 50 pce
Description (DE)
ANTABUS Dispergetten Tabl 400 mg Ds 50 Stk
Market launch
01/12/1949
Narcotic (BTM)
No
Buy us a coffee Explore the data